紫癜,血小板减少性

紫癜,血小板减少性的相关文献在1999年到2021年内共计124篇,主要集中在内科学、儿科学、药学 等领域,其中期刊论文124篇、专利文献468942篇;相关期刊60种,包括国际检验医学杂志、中华血液学杂志、中国小儿血液与肿瘤杂志等; 紫癜,血小板减少性的相关文献由408位作者贡献,包括侯明、杨林花、冯建军等。

紫癜,血小板减少性—发文量

期刊论文>

论文:124 占比:0.03%

专利文献>

论文:468942 占比:99.97%

总计:469066篇

紫癜,血小板减少性—发文趋势图

紫癜,血小板减少性

-研究学者

  • 侯明
  • 杨林花
  • 冯建军
  • 陈剑芳
  • 伍昌林
  • 刘仿
  • 刘秀娥
  • 周永明
  • 周韶虹
  • 孙建芝
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 罗爽; 花京剩; 孙景宇
    • 摘要: 目的 探讨升血小板胶囊联合重组人血小板生成素治疗难治性特发性血小板减少性紫癜(ITP)的效果及对血小板参数及免疫调节因子的影响.方法 82例难治性ITP患者随机分为观察组和对照组,各41例.对照组予重组人血小板生成素治疗,观察组在对照组的基础上予升血小板胶囊治疗.比较两组疗效、血小板参数[血小板计数(PLT)、血小板体积分布宽度(PDW)、血小板比容(PCT)及血小板平均体积(MPV)]、免疫调节因子指标[肿瘤坏死因子-α(TNF-α)、干扰素-γ(INF-γ)、白介素-10(IL-10)及IL-4水平]及不良反应发生情况.结果 观察组治疗总有效率显著高于对照组(P<0.05).治疗后,观察组PLT及PCT水平均显著高于对照组,PDW及MPV水平均显著低于对照组(均P<0.05);观察组IL-10及IL-4水平均显著高于对照组,TNF-α及INF-γ水平均显著低于对照组(均P< 0.05).两组不良反应发生率差异无统计学意义(P>0.05).结论 升血小板胶囊联合重组人血小板生成素治疗难治性ITP疗效较好,且安全可靠,其作用原因可能与改善血小板参数及免疫调节因子水平有关.
    • 纪怡璠; 许静; 陈慧芳; 李杰; 董艳红; 吕佩源
    • 摘要: cqvip:1病例报告患者女,55岁。因“间断胸闷、乏力伴皮肤出血半年余”于2020-07-04入院。半年前出现胸闷、乏力,伴皮肤、口腔黏膜等间断出血点或瘀斑,有时出血不易自止。无头痛、发热、咳嗽等。2020-07-01曾就诊当地医院,行头颅CT检查结果未见异常;血常规检查示血红蛋白77 g/L,血小板6×10^(9)/L;血生化显示总胆红素60.6μmol/L,间接胆红素45.1μmol/L,乳酸脱氢酶939 U/L。先后给予血小板2个治疗剂量静脉输血,第2次输注后患者出现发热达38°C以上,对症处理后好转,但血小板计数未见明显增长,遂转至作者医院治疗。
    • 朱世荣; 李雨蒙; 王明镜; 范腾; 刘为易; 曲文闻; 宋敏敏; 胡晓梅
    • 摘要: 免疫性血小板减少症(immune thrombocytopenia,ITP)为临床常见的出血类疾病,属中医“紫癜病”范畴.胡晓梅主任从三焦虚实论治ITP,强调“三焦重在明病位,虚实重在详病性”,认为“上焦多实,中焦虚实夹杂,下焦多虚”,将三焦辨证与八纲辨证中虚实相结合治疗ITP,临床疗效显著.
    • 戴韵馨
    • 摘要: 成人常见的血栓性微血管病(thrombotic microangiopathy,TMA)包括血栓性血小板减少性紫癜(thrombotic thrombocytopenic purpura,TTP)和非典型性溶血尿毒综合征(atypical haemolytic uraemic syndrome,aHUS).TTP与aHUS有着相近的临床表现,且aHUS为公认的补体相关性疾病.许多学者推测补体过度活化在TTP的发病中发挥了一定的作用,并有部分体内和体外研究为据.本文纵览近年来的国内外文献,对TTP可能是补体相关性疾病的观点作一综述.
    • 刘园园; 李儒贵; 胡波; 李金科; 谭华炳
    • 摘要: 1例既往有肺结核病史的53岁男性患者因出现低热、多汗伴轻微干咳,在他院被诊断为"肺结核",给予四联抗结核药物(异烟肼、利福平、吡嗪酰胺、乙胺丁醇)治疗.用药第11天,患者出现鼻出血和下肢瘀斑,瘀斑快速扩展至全身;第13天入我院,血常规检查示PLT 1×109/L,多层螺旋CT检查示右下肺感染(非肺结核性).停用抗结核药物,予升血小板、抗过敏、止血、抗感染等治疗.治疗第4天,患者体温恢复正常,鼻出血停止,PLT 18×109/L;第7天,全身瘀斑消退,PLT 92× 109/L;第16天,PLT 151×109/L,多层螺旋CT检查示右下肺病灶吸收.%A 53-year-old male patient who had a history of pulmonary tuberculosis with fever, hyperhidrosis with slight cough,in other hospital diagnosed as pulmonary tuberculosis,received quadruple anti tuberculosis therapy(isoniazid,rifampicin,pyrazinamide and ethambutol). On the 11th day of therapy,patients developed nasal bleeding and lower extremity ecchymosis petechiae,rapidly expanding to the whole body. On the 13th day,the patient was sent to our hospital,the blood routine examination showed his blood platelet count(PLT)was 1×109/L,the antituberculous drugs were discontinued,and the treatment of raising platelets,anti allergy,hemostasis and anti infection was given. On the 4th day of treatment,the patient's temperature returned to normal,the nasal bleeding stopped,and PLT was 18×109/L. On the 7th day,his body ecchymosis subside,and PLT was 92×109/L. On the 16th day,his PLT was 151×109/L, and multi-slice spiral CT examination showed right lower lung lesion was absorbed.
    • 李方方; 李天宇; 徐大明; 张茜
    • 摘要: [Objective]To analyze the correlation between non-receptor protein tyrosine phosphatase 22 (PTPN22) gene polymorphism and the susceptibility of idiopathic thrombocytopenic purpura (ITP) in children.[Methods]Gene polymorphism of PTPN22-1123G>C (rs2488457) in 120 children with ITP (the observation group) and 80 normal children (the control group) was determined by PCR-MALDI-TOF MS method.[Results]The C frequency of PTPN22-1123G > C allele in the observation group was 62.50% ,which was significantly lower than that in the control group (71.25%) (P0.05).The allele frequency showed significant differences in boys in the two groups (P0.05).There were no significant differences in genotypes in children with the same gender (P>0.05).[Conclusion]The PTPN22-1123G>C polymorphism is associated with susceptibility of ITP in children.C is the dominant allele while G is the risk allele.The allele frequencies of PTPN22-1123G > C may be related to the gender of children.%[目的]分析非受体型蛋白酪氨酸磷酸酶22(PTPN22)基因多态性与儿童血小板减少性紫癜(ITP)易感性的关联性.[方法]通过复合PCR和基质辅助激光解电离析飞行时间质谱(PCR-MALDI-TOF-MS)法对120例ITP患儿(观察组)及80例正常儿童(对照组)PTPN22基因-1123G>C(rs2488457)测定.[结果]观察组PTPN22-1123G>C等位基因中C频率62.50%,较对照组的71.25%差异有统计学意义(P0.05);观察组与对照组男童等位基因频率比较差异显著(P0.05),两组同一性别基因型比较差异均无统计学意义(P>0.05).[结论]PTPN22-1123G>C多态性与儿童ITP易感性有关,C为优势等位基因,G为风险等位基因,PTPN22-1123G>C等位基因频率分布可能与儿童性别相关.
    • 蒋成龙; 涂兵
    • 摘要: Traditionally,splenectomy is the second-line treatment method of primary thrombocytopenic purpura and a choice after the ineffectual treatment of glucocorticoid,but doctors never evaluate the curative effect of splenectomy before the operation and assess the necessity of splenectomy.In light of recent progresses on this topic,the current review summaries and pinpoints traditional application of splenectomy,side effects,new drug,and predicted factors of evaluation of operation,aiming to make accurate splenectomy for idiopathic thrombocytopenic purpura.%在传统治疗方式中,脾切除术是原发性血小板减少性紫癜的二线治疗方式,一般是在应用糖皮质激素药物治疗效果不佳后的选择,但临床在术前从未评价过脾切除术对于患者的疗效,未评估是否有实施脾切除术的必要性.本文将结合国内外文献,对脾切除的传统应用、不良反应、新药的代替治疗及手术效果的预测因素进行分析,以期待在治疗原发性血小板减少性紫癜时能做到精准脾切除术.
    • 陈玙; 董春霞; 王梅芳; 韩孟汝; 郭建利; 王刚; 杨林花
    • 摘要: 目的 提高对嗜血细胞综合征(HPS)合并血栓性血小板减少性紫癜(TTP)的诊治认识.方法 回顾性分析1例HPS表现有TTP患者的临床资料,并进行相关文献复习.结果 患者诊断为HPS合并TTP,从发病至死亡不足1个月,关于此类病例的报道少见.结论 HPS患者本身可出现血小板计数显著减少,当同时表现有TTP时,极易误诊或延误诊断.
    • 雷瑚仪; 封蔚莹; 兰梅; 王英侠; 陈岳华
    • 摘要: 目的 对特发性血小板减少性紫癜(ITP)患者的核因子-κB(NF-κB)、幽门螺杆菌(Hp)、幽门螺杆菌细胞毒素相关蛋白A(CagA)、血小板(PLT)、血小板相关IgG抗体(PA-IgG)进行检测分析,探讨NF-κB、cagA在ITP发病机制中的作用,寻找改善ITP预后的方法.方法 SABC法检测NF-κB,C13尿素呼气试验(uBT)检测Hp,酶联免疫法测定外周血cagA、PA-IgG,全自动血细胞分析仪测定PLT.依据检测结果将患者分为Hp+cagA+NF-κB+、Hp+cagA+NF-κB-、Hp+cagA-NF-κB+、Hp+cagA-NF-κB-、Hp-NF-κB+、Hp-NF-κB-六组.对各组PA-IgG、PLT进行统计学分析.结果 224例ITP,Hp阳性175例,阳性率78.13%.175例Hp+,其中cagA+91例,Hp+中占52%,总体中占43.63%.NF-κB+共108例,总阳性率46.21%;其中Hp+cagA+中78例,阳性率85.71%;Hp+cagA-中21例,阳性率25%;49例Hp-中9例NF-κB+,占18.37%.分析各组PLT、PA-IgG,Hp+较Hp-组,Hp+cagA+较Hp+cagA-组,NF-κB+较NF-κB-组,PLT低、PA-IgG高,差异有统计学意义(P<0.05).结论 cagA可能直接或通过激活NF-κB参与免疫应答,致ITP患者PA-IgG升高,血小板降低.%Objective To detect and analyze nuclear factor kappa B (NF-κB),Helicobacter pylori (HP),Helicobacter pylori cytotoxin associated protein A (CagA),platelet (PLT) and platelet associated IgG (PA IgG) in 224 patients with idiopathic thrombocytopenic purpur(ITP) from three urban hospitals of Shaoxing,in order to explore the role of NF-κB and CagA in the pathogenesis of ITP,then to improve the prognosis of ITP.Methods SABC method was used to detect the NF-κB,13C breath test for the determination of the Hp infection.CagA and PA-IgG were tested by enzyme linked immunosorbent assay.Automatic blood cell analyzer was used to measure PLT.According to the test results,the patients were divided into Hp+cagA+NF-κB+,Hp+cagA+NF-κB-,Hp+cagA-NF-κB+,Hp+cagA-NF-κB-,Hp-NF-κB+,Hp-NF-κB-PLT groups,and PA-IgG,PLT of the six groups were statistically analyzed.Results Of 224 cases with ITP,175 cases of HP positive,the positive rate was 78.13%.CagA+ 91 cases in 175 cases of Hp+,accounting for 52%,overall 43.63%.NF-kappa B+ 108 cases,the positive rate was 46.21%,78 cases were found in Hp+cagA+,accounting for 85.71% in cagA+.In 84 cases of Hp+cagA-,there were 21 cases NF-κB+,the positive rate was 25%.In 49 of HP-,9 cases with NF-kappa B+,accounting for 18.37%.PLT and PA-IgG were compared among the groups.The count of PLT of group Hp+,group Hp+cagA+ and group NF-κB+ was lower than group Hp-,group Hp+cagA- and group NF-κB-.However,the level of PA-IgG of group Hp+,group Hp+cagA+ and group NF-κB+ was higher than group Hp-,group Hp+cagA- and group NF-κB-,the difference was statistically significant(P<0.05).Conclusion CagA maybe directly or through the activation of NF-kappa B take part in the immune response of ITP,cause PA-IgG increased and thrombocytopenia.
    • 苏美云; 侯正军; 叶舒婷
    • 摘要: 目的 比较不同剂量丙种球蛋白联合糖皮质激素治疗特发性血小板减少性紫癜(ITP)的疗效.方法 按照随机数字表法将86例ITP患者分为大剂量组(n=29)、小剂量组(n=29)和对照组(n=28).对照组给予糖皮质激素及常规基础治疗,大剂量组给予丙种球蛋白400 mg·kg-1·d-1联合糖皮质激素治疗,小剂量组给予丙种球蛋白200 mg·kg-1·d-1联合糖皮质激素治疗.结果 大剂量组和小剂量组有效率高于对照组(P<0.05),但大剂量组与小剂量组差异无统计学意义(P>0.05);大剂量组和小剂量组血小板开始上升时间及血小板上升至正常时间均较对照组短(均P< 0.05),但大剂量组与小剂量组差异均无统计学意义(均P>0.05).结论 对ITP患者给予糖皮质激素常规治疗的基础上联合丙种球蛋白治疗具有显著的临床疗效,有助于血小板水平的快速提高,且小剂量丙种球蛋白与大剂量治疗效果相当,因此临床上可选择小剂量丙种球蛋白进行治疗.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号